A phase I/II trial of ketoconazole + calcitriol [1,25(OH)2D3] in castration-resistant prostate cancer

Authors :: William E. Brady
Jeanny B. Aragon-Ching
Roberto Pili
Donald L. Trump
Candace S. Johnson
Saby George
Ellis G. Levine
Source :: Journal of Clinical Oncology. 34:5065-5065
Publication Year :: 2016
Publisher :: American Society of Clinical Oncology (ASCO), 2016.
Abstract: 5065Background: Considerable evidence indicates that exposure of tumor cells to high concentrations of 1,25(OH)2 vitamin D3 [1,25D3] in vitro can suppress in vivo tumor growth. Several studies have...

Subjects :: Vitamin
Cancer Research
Calcitriol
business.industry
Castration resistant
medicine.disease
In vitro
chemistry.chemical_compound
Prostate cancer
Phase i ii
Oncology
chemistry
In vivo
medicine
Cancer research
Ketoconazole
business
medicine.drug

Full Text Access

Tools